| Dr Mark A Mitchell, DO | |
|
2150 Gettler St Ste 400, Dyer, IN 46311-2385 | |
| (219) 865-0893 | |
| (219) 865-3599 |
| Full Name | Dr Mark A Mitchell |
|---|---|
| Gender | Male |
| Speciality | Cardiac Electrophysiology |
| Experience | 24 Years |
| Location | 2150 Gettler St Ste 400, Dyer, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265552756 | NPI | - | NPPES |
| 200911930 | Medicaid | IN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Franciscan Health Dyer | Dyer, IN | Hospital |
| Franciscan Health Munster | Munster, IN | Hospital |
| Franciscan Health Crown Point | Crown point, IN | Hospital |
| Community Hospital | Munster, IN | Hospital |
| Franciscan Health Olympia Fields & Chicago Heights | Olympia fields, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Franciscan Physician Network | 3072790682 | 989 |
News Archive
Familial risk for psychosis does not account for the association between abuse during childhood and the later development of schizophrenia, a study suggests.
To look at the tobacco budworm moth and its close cousin, you wouldn't be able to tell the fuzzy-looking, fingertip-size moths apart. But put males of each species as far as six car-lengths away from females, and even in the darkness of midnight they easily find their way to mates from their own species while ignoring females from the other species. Today, the genes that keep the species sexually isolated are no longer a mystery, thanks to research from North Carolina State University and the University of Utah.
Postmastectomy radiation therapy for some breast cancer patients can reduce their risk of recurrence by almost 30 percent and increase their five-year overall survival by almost 50 percent, according to a study in the June 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology.
Liver toxicity is one of the main reasons pharmaceutical companies pull drugs off the market. These dangerous drugs slip through approval processes due in part to the shortcomings of liver toxicity tests. Existing tests rely on liver cells from rats, which do not always respond to toxins the way human cells do. Or they rely on dying human cells that survive for only a few days in the lab.
Cepheid and Instrumentation Laboratory (IL) today announced that Cepheid has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert(R) HemosIL(R) FII & FV test.
› Verified 9 days ago
| Entity Name | Franciscan Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225327984 PECOS PAC ID: 3072790682 Enrollment ID: O20110608000486 |
News Archive
Familial risk for psychosis does not account for the association between abuse during childhood and the later development of schizophrenia, a study suggests.
To look at the tobacco budworm moth and its close cousin, you wouldn't be able to tell the fuzzy-looking, fingertip-size moths apart. But put males of each species as far as six car-lengths away from females, and even in the darkness of midnight they easily find their way to mates from their own species while ignoring females from the other species. Today, the genes that keep the species sexually isolated are no longer a mystery, thanks to research from North Carolina State University and the University of Utah.
Postmastectomy radiation therapy for some breast cancer patients can reduce their risk of recurrence by almost 30 percent and increase their five-year overall survival by almost 50 percent, according to a study in the June 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology.
Liver toxicity is one of the main reasons pharmaceutical companies pull drugs off the market. These dangerous drugs slip through approval processes due in part to the shortcomings of liver toxicity tests. Existing tests rely on liver cells from rats, which do not always respond to toxins the way human cells do. Or they rely on dying human cells that survive for only a few days in the lab.
Cepheid and Instrumentation Laboratory (IL) today announced that Cepheid has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert(R) HemosIL(R) FII & FV test.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark A Mitchell, DO Po Box 781076, Detroit, MI 48278-1076 Ph: (317) 528-4800 | Dr Mark A Mitchell, DO 2150 Gettler St Ste 400, Dyer, IN 46311-2385 Ph: (219) 865-0893 |
News Archive
Familial risk for psychosis does not account for the association between abuse during childhood and the later development of schizophrenia, a study suggests.
To look at the tobacco budworm moth and its close cousin, you wouldn't be able to tell the fuzzy-looking, fingertip-size moths apart. But put males of each species as far as six car-lengths away from females, and even in the darkness of midnight they easily find their way to mates from their own species while ignoring females from the other species. Today, the genes that keep the species sexually isolated are no longer a mystery, thanks to research from North Carolina State University and the University of Utah.
Postmastectomy radiation therapy for some breast cancer patients can reduce their risk of recurrence by almost 30 percent and increase their five-year overall survival by almost 50 percent, according to a study in the June 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology.
Liver toxicity is one of the main reasons pharmaceutical companies pull drugs off the market. These dangerous drugs slip through approval processes due in part to the shortcomings of liver toxicity tests. Existing tests rely on liver cells from rats, which do not always respond to toxins the way human cells do. Or they rely on dying human cells that survive for only a few days in the lab.
Cepheid and Instrumentation Laboratory (IL) today announced that Cepheid has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert(R) HemosIL(R) FII & FV test.
› Verified 9 days ago
Dr. Sumanth Mulamalla, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15900 W 101st Ave, Dyer, IN 46311 Phone: 219-365-6333 Fax: 219-365-8291 | |
Eshwar Nagraj Murthy, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Joliet St, Dyer, IN 46311 Phone: 219-865-2141 Fax: 219-933-2288 | |
Mohamad Kassar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Calumet Ave, Dyer, IN 46311 Phone: 219-924-8178 Fax: 219-924-8179 | |
Dr. Beder Pharaon, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Joliet St, Dyer, IN 46311 Phone: 219-865-2141 Fax: 219-852-2502 | |
C Richard Smith, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2150 Gettler St Ste 400, Dyer, IN 46311 Phone: 219-865-0893 Fax: 219-865-3599 | |
Dr. Vladimir Selounski, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Joliet St, Dyer, IN 46311 Phone: 219-865-2141 Fax: 219-852-2502 | |
Brandon Keith Nance, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Joliet St, Dyer, IN 46311 Phone: 219-865-2141 Fax: 219-865-2141 |